Professor Gerald Holtmann
Professor

Gerald Holtmann

Email: 
Phone: 
+61 7 3176 7792

Background

Prof Holtmann is a Clinical Academic in the field of Gastroenterology & Hepatology and Director of Clinical Innovation. He is also Director of the Department of Gastroenterology & Hepatology at the Princess Alexandra Hospital in Queensland and serves on the Board of Directors of the West Moreton Hospital and Health Service and UQ Healthcare. He is a Fellow of Royal Australian Collge of Physicians (RACP, Sydney), the Royal College of Physicians (RCP, London) and Fellow of the Australian Academy of Health and Medical Sciences (AAHMS, Canberra). Besides his Medical Qualifications he also obtained a Master of Business Administration. After completing the clinical training in Medicine and Gastroenterology at the University of Essen in Germany and the Mayo Clinic in Rochester, Minnesota in the United States, he has gained substantial leadership and managerial experience within the health care setting as Director of large Gastroenterology Departments, CEO and General Manager of a University Hospital and Health Care Facilities and has served on the Board of the University Hospital Essen in Germany. His research is in the field of Neurogastroenterology has resulted in peer reviewed publications in key journal including the NEJM, Lancet, Gastroenterology and Gut. More recently his rersearch focus is on the role of the gut microbiome, mucosal and systemic inflammation and brain-gut interactions.

Availability

Professor Gerald Holtmann is:
Available for supervision
Media expert

Search Professor Gerald Holtmann’s works on UQ eSpace

531 works between 1986 and 2025
All (531) Journal Article (397) Book Chapter (4) Conference Publication (130)

421 - 440 of 531 works

2003

Journal Article

Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin

Lauenstein, Thomas C., Vogt, Florian M., Herborn, Christoph U., DeGreiff, Armin, Debatin, Jörg F. and Holtmann, Gerald (2003). Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. American Journal of Roentgenology, 180 (5), 1305-1310. doi: 10.2214/ajr.180.5.1801305

Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin

2003

Journal Article

Reflux disease and Barrett's esophagus

Haag, S. and Holtmann, G. (2003). Reflux disease and Barrett's esophagus. Endoscopy, 35 (2), 112-117. doi: 10.1055/s-2003-37013

Reflux disease and Barrett's esophagus

2003

Journal Article

Effects of a fixed combination of peppermint oil and caraway oil on symptoms and quality of life in patients suffering from functional dyspepsia

Holtmann, Gerald, Haag, S., Adam, B., Funk, Petra, Wieland, Veronika and Heydenreich, Claus-Jürgen (2003). Effects of a fixed combination of peppermint oil and caraway oil on symptoms and quality of life in patients suffering from functional dyspepsia. Phytomedicine, 10 (SUPPL. 4), 56-57. doi: 10.1078/1433-187X-00310

Effects of a fixed combination of peppermint oil and caraway oil on symptoms and quality of life in patients suffering from functional dyspepsia

2002

Journal Article

Diagnostic criteria and therapeutic strategies of abdominal pain syndromes Diagnostische kriterien von und therapeutische strategien bei schmerzen des magen-darm-trakts und der beckenorgane

Gschossmann, J. M., Häuser, W., Wesselmann, U. and Holtmann, G. (2002). Diagnostic criteria and therapeutic strategies of abdominal pain syndromes Diagnostische kriterien von und therapeutische strategien bei schmerzen des magen-darm-trakts und der beckenorgane. Schmerz, 16 (6), 476-480. doi: 10.1007/s00482-002-0192-8

Diagnostic criteria and therapeutic strategies of abdominal pain syndromes Diagnostische kriterien von und therapeutische strategien bei schmerzen des magen-darm-trakts und der beckenorgane

2002

Journal Article

Epidemiology and clinical phenomenology of visceral pain Epidemiologie und klinische phänomenologie viszeraler schmerzen

Gschossmann, Juergen M., Holtmann, G. and Mayer, E. A. (2002). Epidemiology and clinical phenomenology of visceral pain Epidemiologie und klinische phänomenologie viszeraler schmerzen. Schmerz, 16 (6), 447-451. doi: 10.1007/s00482-002-0188-4

Epidemiology and clinical phenomenology of visceral pain Epidemiologie und klinische phänomenologie viszeraler schmerzen

2002

Journal Article

Effect of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension

Gschossmann, Jürgen M., Adam, Birgit, Liebregts, Tobias, Buenger, Lydia, Ruwe, Michael, Gerken, Guido, Mayer, Emeran A. and Holtmann, Gerald (2002). Effect of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension. European Journal of Gastroenterology and Hepatology, 14 (10), 1067-1072. doi: 10.1097/00042737-200210000-00006

Effect of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension

2002

Journal Article

A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia

Holtmann, G., Gschossmann, J., Mayr, P. and Talley, N. J. (2002). A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Alimentary Pharmacology and Therapeutics, 16 (9), 1641-1648. doi: 10.1046/j.1365-2036.2002.01322.x

A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia

2002

Journal Article

Gastrocolic fistula - A rare cause of cachexia and polyneuropathy Gastrokolische fistel als seltene ursache von kachexie und polyneuropathie

Schneider, A., Holtmann, Gerald, Rünzi, M., Drochner, K., Oldhafer, K. J. and Gerken, G. (2002). Gastrocolic fistula - A rare cause of cachexia and polyneuropathy Gastrokolische fistel als seltene ursache von kachexie und polyneuropathie. Zeitschrift fur Gastroenterologie, 40 (7), 521-524. doi: 10.1055/s-2002-32800

Gastrocolic fistula - A rare cause of cachexia and polyneuropathy Gastrokolische fistel als seltene ursache von kachexie und polyneuropathie

2002

Journal Article

Capsaicin-sensitive nerve fibres induce epithelial cell proliferation, inflammatory cell immigration and transforming growth factor-alpha expression in the rat colonic mucosa in vivo

Hoffmann, Peter, Mazurkiewicz, J., Holtmann, G., Gerken, G., Eysselein, V. E. and Goebell, H. (2002). Capsaicin-sensitive nerve fibres induce epithelial cell proliferation, inflammatory cell immigration and transforming growth factor-alpha expression in the rat colonic mucosa in vivo. Scandinavian Journal of Gastroenterology, 37 (4), 414-422. doi: 10.1080/003655202317316042

Capsaicin-sensitive nerve fibres induce epithelial cell proliferation, inflammatory cell immigration and transforming growth factor-alpha expression in the rat colonic mucosa in vivo

2002

Journal Article

A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease

Holtmann, G., Bytzer, P., Metz, M., Loeffler, V. and Blum, A. L. (2002). A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics, 16 (3), 479-485. doi: 10.1046/j.1365-2036.2002.01207.x

A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease

2002

Journal Article

Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?

Holtmann, Gerald, Gschossmann, Juergen, Buenger, Lydia, Gerken, Guido and Talley, Nicholas J. (2002). Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?. Gastroenterology, 123 (5) 00278, 1451-1458. doi: 10.1053/gast.2002.36556

Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?

2002

Journal Article

MR colonography with barium-based fecal tagging: Initial clinical experience

Lauenstein, Thomas C., Goehde, Susanne C., Ruehm, Stefan G., Holtmann, Gerald and Debatin, Jörg F. (2002). MR colonography with barium-based fecal tagging: Initial clinical experience. Radiology, 223 (1), 248-254. doi: 10.1148/radiol.2231010887

MR colonography with barium-based fecal tagging: Initial clinical experience

2002

Journal Article

(Post) inflammatory visceral hyperalgesia: Don't we believe what we don't see?

Holtmann, Gerald (2002). (Post) inflammatory visceral hyperalgesia: Don't we believe what we don't see?. Gastroenterology, 122 (3), 823-825. doi: 10.1053/gast.2002.32113

(Post) inflammatory visceral hyperalgesia: Don't we believe what we don't see?

2001

Journal Article

Epithelial cell-derived components induce transforming growth factor-α mRNA expression and epithelial cell proliferation in vitro

Hoffmann, Peter, Dignass, Axel U., Zeeh, Jörg M., Mazurkiewicz, Jessica, Holtmann, Gerald and Gerken, Guido (2001). Epithelial cell-derived components induce transforming growth factor-α mRNA expression and epithelial cell proliferation in vitro. European Journal of Gastroenterology and Hepatology, 13 (11), 1333-1340. doi: 10.1097/00042737-200111000-00012

Epithelial cell-derived components induce transforming growth factor-α mRNA expression and epithelial cell proliferation in vitro

2001

Journal Article

Guidelines of the German Society of Metabolic and Digestive Diseases for the therapy of dyspesia Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zur behandlung der dyspepsie

Malfertheiner, P., Holtmann, G., Peitz, U., Birkner, B., Arnold, R., Hotz, J., Leodolter, A., Mössner, J. and Robra, B. P. (2001). Guidelines of the German Society of Metabolic and Digestive Diseases for the therapy of dyspesia Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zur behandlung der dyspepsie. Zeitschrift fur Gastroenterologie, 39 (11), 937-956. doi: 10.1055/s-2001-18536

Guidelines of the German Society of Metabolic and Digestive Diseases for the therapy of dyspesia Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zur behandlung der dyspepsie

2001

Journal Article

Epidemiological trends of functional gastrointestinal disorders

Gschossmann, J. M., Haag, S. and Holtmann, Gerald (2001). Epidemiological trends of functional gastrointestinal disorders. Digestive Diseases, 19 (3), 189-194. doi: 10.1159/000050679

Epidemiological trends of functional gastrointestinal disorders

2001

Journal Article

Diurnal variation of abdominal motor responses to colorectal distension and plasma cortisol levels in rats

Gschossmann, J. M., Buenger, L., Adam, B., Liebregts, T., Saller, B., Mann, K., Gerken, G. and Holtmann, G. (2001). Diurnal variation of abdominal motor responses to colorectal distension and plasma cortisol levels in rats. Neurogastroenterology and Motility, 13 (6), 585-589. doi: 10.1046/j.1365-2982.2001.00293.x

Diurnal variation of abdominal motor responses to colorectal distension and plasma cortisol levels in rats

2001

Journal Article

Treatment of functional dyspepsia (irritable bowel syndrome) Therapie der funktionellen dyspepsie (reizmagensyndrom)

Holtmann, G. (2001). Treatment of functional dyspepsia (irritable bowel syndrome) Therapie der funktionellen dyspepsie (reizmagensyndrom). Internist, 42 (9), 1261-1269. doi: 10.1007/s001080170079

Treatment of functional dyspepsia (irritable bowel syndrome) Therapie der funktionellen dyspepsie (reizmagensyndrom)

2001

Journal Article

Chronic intestinal pseudo-obstruction: Clinical symptomatology an course Die chronische intestinale pseudoobstruktion: Untersuchung zur klinischen symptomatik und verlauf

Gschossmann, J. M., Holtmann, G., Bünger, L., Grandt, D., Drochner, K. and Gerken, G. (2001). Chronic intestinal pseudo-obstruction: Clinical symptomatology an course Die chronische intestinale pseudoobstruktion: Untersuchung zur klinischen symptomatik und verlauf. Deutsche Medizinische Wochenschrift, 126 (36), 964-969. doi: 10.1055/s-2001-16967

Chronic intestinal pseudo-obstruction: Clinical symptomatology an course Die chronische intestinale pseudoobstruktion: Untersuchung zur klinischen symptomatik und verlauf

2001

Journal Article

H. pylori and functional dyspepsia. Increased serum antibodies as an independent risk factor?

Holtmann, G., Gschossmann, J., Holtmann, M. and Talley, N. J. (2001). H. pylori and functional dyspepsia. Increased serum antibodies as an independent risk factor?. Digestive Diseases and Sciences, 46 (7), 1550-1557. doi: 10.1023/A:1010612509593

H. pylori and functional dyspepsia. Increased serum antibodies as an independent risk factor?

Current funding

  • 2022 - 2026
    ARC Training Centre for Behavioural Insights for Technology Adoption (BITA) (ARC Industrial Transformation Training Centre Administered by QUT)
    Queensland University of Technology
    Open grant
  • 2021 - 2025
    A practice change for patients with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled intervention to assess efficacy and cost-effectiveness
    NHMRC IDEAS Grants
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2014 - 2017
    Functional dyspepsia: Characterisation of the immunopathology and testing a novel therapeutic strategy (NHMRC Project Grant administered by the University of Newcastle)
    University of Newcastle
    Open grant

Availability

Professor Gerald Holtmann is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Effects the COVID-19 pandemic on the outcome and management of highly prevalent gastrointestinal conditions

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Effects the COVID-19 pandemic on the outcome and management of highly prevalent gastrointestinal conditions

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Effects the COVID-19 pandemic on the outcome and management of highly prevalent gastrointestinal conditions

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Reimagining Health Equity and Access in Colorectal Cancer Screening. A population perspective.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Equitability and Accessibility of Faecal Occult Blood Test Based Colorectal Cancer Screening for Disadvantaged Communities.

    Principal Advisor

  • Doctor Philosophy

    Reimagining Health Equity and Access in Colorectal Cancer Screening. A population perspective

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    IBD and mental health tools: a holistic approach to discovery and appropriate tool.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Exercise training on people with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled trial.

    Associate Advisor

    Other advisors: Professor Jeff Coombes

  • Doctor Philosophy

    The role of the gut microbiome in alcohol related liver disease

    Associate Advisor

    Other advisors: Professor Jason Connor, Dr Paul Clark

  • Doctor Philosophy

    Study of TOfacitinib for the treatment of chronic Pouchitis

    Associate Advisor

    Other advisors: Associate Professor Jakob Begun

  • Doctor Philosophy

    Study of TOfacitinib for the treatment of chronic Pouchitis

    Associate Advisor

    Other advisors: Associate Professor Jakob Begun

Completed supervision

Enquiries

Contact Professor Gerald Holtmann directly for media enquiries about:

  • colon cancer screening
  • Gastroenterology
  • Gut Health
  • Microbiome
  • Neurogastroenterology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au